Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Lidocaine 5% medicated plasters

Brand: Versatis®
Indication: Post Herpetic Neuralgia (as per LMMG Guidelines)
Disease category: Anaesthesia
Commissioning responsibility: CCG
PbR excluded: No


Lidocaine 5% medicated plasters are recommended as an option for the treatment of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia) in adults.
Initiation should only be after first line topical and systemic therapies have either failed or led to intolerable side effects, as per the LMMG Neuropathic Pain Guidance. An assessment of the tolerance and efficacy should be made after 2 – 4 weeks of treatment initiation, before continuation.
After three months of treatment there should be an assessment as to whether the number of patches can be reduced or the patch free interval can be extended.

This colour classification is in agreement with the recommendations contained within the NHS England and NHS Clinical Commissioners guidance document ‘Items which should not routinely be prescribed in primary care: Guidance for CCGs‘ published in November 2017


LMMG recommendation: Green
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for initiation in primary care in line with Neuropathic Pain Guideline

Supporting documents:

New Medicine Assessment - Lidocaine 5% medicated plasters in PHN

Neuropathic Pain Guidance (Version 1.2) (846.6 KiB)

Unlicensed Medicines for Neuropathic Pain (Version 1.0) (210.2 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG



Green (Restricted)